Fasting remnant lipoproteins can predict postprandial hyperlipidemia

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Nagata, Tomoki ^a,f   Sugiyama, Daisuke ^b,g   Kise, Takako ^a   Tsuji, Satomi ^a,h   Ohira, Hideo ^a   Sato, Itsuko ^c   Yamamoto, Mari ^c   Kohsaka, Hitomi ^c   Kawano, Seiji ^c   Yamashita, Shizuya ^d   Ishikawa, Yuichi ^e   Fujioka, Yoshio ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KOBE UNIVERSITY HOSPITAL   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e Kakogawa West City Hospital   (Japan)

^f SHIMANE PREFECTURAL CENTRAL HOSPITAL   (Japan)

^g KEIO UNIVERSITY   (Japan)

^h Kakogawa East City Hospital   (Japan)

Author keywords

Adiponectin.; Apolipoprotein B; Postprandial hyperlipidemia; Remnant lipoprotein; Triglyceride

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REMNANT LIKE PARTICLE TRIGLYCERIDE; REMNANT LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; BODY MASS; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; FEMALE; GENDER; HUMAN; HYPERLIPIDEMIA; MALE; NORMAL HUMAN; POSTPRANDIAL HYPERLIPIDEMIA; PREDICTION; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; APOLIPOPROTEINS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FASTING; FEMALE; GASTRIC STUMP; HUMANS; HYPERLIPIDEMIAS; LINEAR MODELS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 84868232072     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-146     Document Type: Article

References (44)

1. on behalf of the American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular N: Triglycerides and cardiovascular disease. A Scientific Statement From the American Heart Association. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, Goldberg AC, Howard WJ, Jacobson MS, Kris-Etherton PM, Lennie TA, Levi M, Mazzone T, Pennathur S, Circulation 2011 123 2292 2333 10.1161/CIR.0b013e3182160726 21502576
2. Serum triglycerides and risk of coronary heart disease among Japanese men and women. Iso H, Naito Y, Sato S, Kitamura A, Okamura T, Sankai T, Shimamoto T, Iida M, Komachi Y, Am J Epidemiol 2001 153 490 499 10.1093/aje/153.5.490 11226981 (Pubitemid 32185086)
3. Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Eberly LE, Stamler J, Neaton JD, For the Multiple Risk Factor Intervention Trial Research Group, Arch Intern Med 2003 163 1077 1083 10.1001/archinte.163.9.1077 12742806 (Pubitemid 36548936)
4. Atherogenesis: a postprandial phenomenon. Zilversmit DB, Circulation 1979 60 473 485 10.1161/01.CIR.60.3.473 222498 (Pubitemid 9254048)
5. Relation of triglyceride metabolism and coronary disease. Studies in the postprandial state. Patsch JR, Miesenböck G, Hopferwieser T, Mühlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsch W, Arterioscler Thromb 1992 12 1336 1345 10.1161/01.ATV.12.11.1336 1420093
6. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM, JAMA 2007 298 309 316 10.1001/jama.298.3.309 17635891 (Pubitemid 47080485)
7. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A, JAMA 2007 298 299 308 10.1001/jama.298.3.299 17635890 (Pubitemid 47080484)
8. Postprandial lipoprotein metabolism and atherosclerosis. Karpe F, Hamsten A, Curr Opin Lipidol 1995 6 123 129 10.1097/00041433-199506000-00003 7648000
9. Triglycerides: a risk factor for coronary heart disease. Davignon J, Cohn JS, Atherosclerosis 1996 124 Suppl 57 S64 8831917
10. Remnant lipoproteins as strong key particles to atherosclerosis. Fujioka Y, Ishikawa Y, J Atheroscler Thromb 2009 16 145 154 10.5551/jat.E598 19556722
11. Significance of measuring serum concentrations of remnant lipoproteins and apolipoprotein B-48 in fasting period. Sato I, Ishikawa Y, Ishimoto I, Katsuta S, Toyokawa A, Hayashi F, Kawano S, Fujioka Y, Yamashita S, Kumagai S, J Atheroscler Thromb 2009 16 12 20 10.5551/jat.E596 19262003
12. cDNA cloning and expression of a novel adipose-specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K, Biochem Biophys Res Commun 1996 221 286 289 10.1006/bbrc.1996.0587 8619847 (Pubitemid 26136463)
13. Metabolic syndrome: clinical concept and molecular basis. Funahashi T, Matsuzawa Y, Ann Med 2007 39 482 494 10.1080/07853890701491026 17852038 (Pubitemid 350035569)
14. Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism. Chan DC, Watts GF, Ng TWK, Uchida Y, Sakai N, Yamashita S, Barrett PHR, Clin Chem 2005 51 578 585 10.1373/clinchem.2004.045120 15650029 (Pubitemid 40300234)
15. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE, Diabetologia 2003 46 459 469 12687327 (Pubitemid 36577787)
16. Postprandial plasma adiponectin decreases after glucose and high fat meal and is independently associated with postprandial triacylglycerols but not with -11388 promotor polymorphism. Rubin D, Helwig U, Northnagel M, Lemke N, Schreiber S, Fölsch UR, Döring F, Schrezenmeir J, Br J Nutr 2008 99 76 82 17663805 (Pubitemid 350286141)
17. HMW-Adiponectin associates with triglyceride concentrations in type 1 diabetic patients. Maruyama C, Ishibashi R, Araki R, Koike S, Hirose H, Maruyama T, J Atheroscler Thromb 2009 16 207 216 10.5551/jat.E067 19556717
18. Measurement of small dense low-density lipoprotein particles. Hirano T, Ito Y, Yoshino G, J Atheroscler Thromb 2005 12 67 72 10.5551/jat.12.67 15942115
19. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti A-I immunoaffinity mixed gel. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H, Campos E, Havel RJ, Clin Chim Acta 1993 223 53 71 10.1016/0009-8981(93)90062-9 8143370 (Pubitemid 24050910)
20. Development of a homogeneous assay to measure remnant lipoprotein cholesterol. Miyauchi K, Kayahara N, Ishigami M, Kuwata H, Mori H, Sugiuchi H, Irie T, Tanaka A, Yamashita S, Yamamura T, Clin Chem 2007 53 2128 2135 10.1373/clinchem.2007.092296 17901111 (Pubitemid 350197296)
21. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. Baratta R, Amato S, Degano C, Farina MG, Patanè G, Vigneri R, Frittitta L, J Clin Endocrinol Metab 2004 89 2665 2671 10.1210/jc.2003-031777 15181039 (Pubitemid 38766347)
22. Serum adiponectin is associated with high-density lipoprotein cholesterol, triglycerides, and low-density lipoprotein size in young healthy men. Kazumi T, Kawaguchi A, Hirano T, Yoshino G, Metabolism 2004 53 589 593 10.1016/j.metabol.2003.12.008 15131762 (Pubitemid 38596530)
23. Association of serum adiponectin concentration to lipid and glucose metabolism in healthy humans. Heliövaara MK, Strandberg TE, Karonen SL, Ebeling P, Horm Metab Res 2006 38 336 340 10.1055/s-2006-925407 16718631 (Pubitemid 43864956)
24. Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients. Yoshida H, Hirowatari Y, Kurosawa H, Tada N, Clin Sci 2005 109 297 302 10.1042/CS20040353 15907189 (Pubitemid 41337134)
25. Difference between fasting and nonfasting triglyceridemia; the influence of waist circumference. Oka R, Kobayashi J, Miura K, Nagasawa S, Moriuchi T, Hifumi S, Miyamoto S, Kawaashiri MA, Nohara A, Inazu A, Takeda Y, Mabuchi H, Yagi K, Yamagishi M, J Atheroscler Thromb 2009 16 633 640 10.5551/jat.406 19729868
26. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, Tsunoda R, Sakamoto T, Nakano T, Nakajima K, Ogawa H, Sugiyama S, Yoshimura M, Yasue H, Circulation 1999 99 2858 2860 10.1161/01.CIR.99.22.2858 10359727 (Pubitemid 29258971)
27. Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome. Nakamura T, Takano H, Umetani K, Kawabata K, Obata JE, Kitta Y, Kodama Y, Mende A, Ichigi Y, Fujioka D, Saito Y, Kugiyama K, Atherosclerosis 2005 181 321 327 10.1016/j.atherosclerosis.2005.01.012 16039286 (Pubitemid 41019613)
28. Relation between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes. Ai M, Tanaka A, Ogita K, Sekine M, NumanoF NF, Reaven GM, J Am Coll Cardiol 2001 38 1628 1632 10.1016/S0735-1097(01)01611-4 11704373 (Pubitemid 33065446)
29. Lecithin: Cholesterol acyltransferase-from biochemistry to role in cardiovascular disease. Rousset X, Vaisman B, Amar M, Sethi AA, Remaley AT, Curr Opin Endocrinol Diabetes Obes 2009 16 163 171 10.1097/MED.0b013e328329233b 19306528
30. Association between small dense low-density lipoprotein and postprandial accumulation of triglyceride-rich remnant-like particles in normotriglyceridemic patients with myocardial infarction. Tsunoda F, Koba S, Hirano T, Ban Y, Iso Y, Suzuki H, Geshi E, Katagiri T, Circ J 2004 68 1165 1172 10.1253/circj.68.1165 15564701 (Pubitemid 40018862)
31. Circadian rhythm of serum concentration of small sense low-density lipoprotein cholesterol. Ogita K, Ai M, Tanaka A, Ito Y, Hirano T, Yoshino G, Shimokado K, Clin Chim Acta 2007 376 96 100 10.1016/j.cca.2006.07.021 16950238 (Pubitemid 44880985)
32. Circadian change of serum concentration of small sense LDL-cholesterol in type 2 diabetic patients. Hirayama S, Soda S, Ito Y, Matsui H, Ueno T, Fukushima Y, Ohmura H, Hanyu O, Aizawa Y, Miida T, Clin Chim Acta 2010 411 253 257 10.1016/j.cca.2009.11.017 19931237
33. Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease. Granér M, Kahri J, Nakano T, Sarna SJ, Niemien MS, Syvänne M, Taskinen MR, Eur J Clin Invest 2006 36 764 770 10.1111/j.1365-2362.2006.01720.x 17032343 (Pubitemid 44569964)
34. Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test. Serin O, Konukoglu D, Firtina S, Mavis O, Horm Metab Res 2007 39 207 211 10.1055/s-2007-970419 17373636 (Pubitemid 46580620)
35. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. Arsenault BJ, Rana JS, Stroes ES, Després JP, Shah PK, Kastelein JJ, Wareham NJ, Boekholdt SM, Khaw KT, J Am Coll Cardiol 2009 55 35 41 10.1016/j.jacc.2009.07.057 20117361
36. Proposed guidelines for hypertriglyceridemia in Japan with non-HDL cholesterol as the second target. Shimano H, Arai H, Harada-Shiba M, Ueshima H, Ohta T, Yamashita S, Gotoda T, Kiyohara Y, Hayashi T, Kobayashi J, Shimamoto K, Bujo H, Ishibashi S, Shirai K, Oikawa S, Saito Y, Yamada N, J Atheroscler Thromb 2008 15 116 121 10.5551/jat.E560 18603817
37. Effects of canola, corn, and olive oils on fasting and postprandial plasma lipoproteins in humans as part of a national cholesterol education program step 2 diet. Lichtenstein AH, Ausman LM, Carrasco W, Jenner JL, Gualtieri LJ, Goldin BR, Ordovas JM, Schaefer EJ, Arterioscler Thromb 1993 13 1533 1542 10.1161/01.ATV.13.10.1533 8399091 (Pubitemid 23303408)
38. Circadian variation of postprandial lipemia. Romon M, Le Fur C, Lebel P, Edmé JL, Fruchart JC, Dallongeville J, Am J Clin Nutr 1997 65 934 940 9094875 (Pubitemid 27152607)
39. LDL-cholesterol and HDL-cholesterol concentrations decrease during the day. Miida T, Nakamura Y, Mezuki T, Hanyu O, Maruyama S, Horikawa Y, Izawa S, Yamada Y, Matsui H, Okada M, Ann Clin Biochem 2002 39 241 249 10.1258/0004563021901946 12038599 (Pubitemid 34494214)
40. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. Mantzoros CS, Li T, Manson JE, Meigs JB, Hu FB, J Clin Endocrinol Metab 2005 90 4542 4548 10.1210/jc.2005-0372 15914524 (Pubitemid 41159340)
41. Association between high molecular weight adiponectin levels and metabolic parameters. Fujimatsu D, Kotooka N, Inoue T, Nishiyama M, Node K, J Atheroscler Thromb 2009 16 553 559 10.5551/jat.1073 19907101
42. Characteristic comparison of triglyceride-rich remnant lipoprotein measurement between a new homogenous assay (RemL-C) and a conventional immunoseparation method (RLP-C). Yoshida H, Kurosawa H, Hirowatari Y, Ogura Y, Ikewaki K, Abe I, Saikawa S, Domitsu K, Ito K, Yanai H, Tada N, Lipids Health Dis 2008 7 18 10.1186/1476-511X-7-18 18485227 (Pubitemid 351748596)
43. Increased remnant lipoprotein in patients with coronary artery disease-evaluation utilizing a newly developed remnant assay, remnant lipoproteins cholesterol homogenous assay (RemL-C). Nakada Y, Kurosawa H, Tohyama J, Inoue Y, Ikewaki K, J Atheroscler Thromb 2007 14 56 64 10.5551/jat.14.56 17485889
44. Effects of supervised aerobic exercise training on serum adiponectin and parameters of lipid and glucose metabolism in subjects with moderate dyslipidemia. Yoshida H, Ishikawa T, Suto M, Kurosawa H, Hirowatari Y, Ito K, Yanai H, Tada N, Suzuki M, J Atheroscler Thromb 2010 17 1160 1166 10.5551/jat.4358 20805637